Verweise von und zu Tyrosine kinase inhibitors
Zurück zum ArtikelVerweise von anderen Artikeln
- Afatinib
- Canities (overview)
- Cetuximab
- Dasatinib
- EGF receptors
- Egfr gene
- Erlotinib
- Exanthema, acneiformes
- Exfoliation areata linguae
- Folliculitis perforating
- Folliculitis superficial
- Gefitinib
- Hypereosinophilia syndrome
- Imatinib
- Collagenosis reactive perforating
- Milia
- Milia multiple eruptive
- Multi-kinase inhibitors
- Sorafenib
- Stevens-johnson syndrome
- Tyrosine kinases
- Vegf
- Vemurafenib
Verweise zu anderen Artikeln
- Acne medicamentosa
- Afatinib
- Autocrine secretion
- Cetuximab
- Dasatinib
- Dermatofibrosarcoma protuberans (overview)
- EGF receptors
- Eosinophilia and skin
- Epidermal growth factor
- Erlotinib
- Gefitinib
- Gemcitabine
- Glucorticosteroids topical
- Hand-foot syndrome
- Urea (overview)
- Her2
- Hypereosinophilia syndrome
- Hypertrichoses
- Imatinib
- KIT gene
- Melanoma acrolentiginous
- Melanoma cutaneous
- Monoclonal antibodies
- Off-label use
- Orphan medicinal products
- Panitumumab
- PDGFR
- Rosacea
- Mucous membrane melanoma
- Scleroderma systemic
- Sorafenib
- Tyrosine kinases
- Vegf
- Vemurafenib
- Growth factors